You are here: Home » Companies » News
Business Standard

Pfizer stops selling popular Corex cough syrup in India after ban

India has banned over 344 drug combinations after a govt panel of experts found that they had no therapeutic justification


Reuters  |  Mumbai 

US pharmaceutical giant Pfizer Inc's India unit said on Monday it had stopped selling its popular Corex cough syrup, after regulators banned it saying it was likely to pose a risk to humans. Corex is a combination of chlopheniramine maleate and codeine syrup, one of 344 drug combinations India banned over the weekend after a government panel of experts found they had 'no therapeutic justification'.Read more from our special coverage on "PFIZER"Pfizer to get patent for cholesterol lowering formulation All these medicines have entered the market over the years based on ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Mon, March 14 2016. 09:56 IST